Lipid modification in GP (Nice update 2021)

11th October 2021 by Dr Louise Hudman

Lipid modification in GP (Nice update 2021)

NICE has recently released guidance on the use of bempedoic acid in lipid modification. This prompted me to look back at the guidance on lipid modification and I came across a useful document from NICE called a ‘Key Therapeutic Topic’.

They are not guidance per se, but outline different medication options and link into other NICE guidance, so they are quite useful. There are plenty of others too.

Given my knowledge of when to add in ezetimibe and the other medications was a bit hazy and given the new guidance on bempedoic acid, I thought it useful to do a bit of a summary on what we should use and when.

What different guidelines are available from NICE on lipid modification?

Read more

No credit card details needed – it takes two minutes.

Join free trial


Already a member? Login to view this content.


More cardiology guidelines

"Since joining NASGP Locum Chambers I have noted a positive change which I feel has made a significant contribution in both my professional and personal life.

LocumDeck's booking system puts me in touch with a large number of surgeries. I work part-time and the software is intricately tailored to facilitate working at my pace and choice.

In addition, I have access to the NASGP Locum Chambers' supporting infrastructure such as the Chambers Manager through whom all my admin work (like generating invoices and pension forms) is organised. In the past this felt like a load. Now I feel that my time is 'freed up' and so I have a better work-life balance. Working with NASGP Locum Chambers has simplified my life."

Dr Smita Iyer, GP, Essex

See the full list of features within our NASGP membership plans